Panacea Biotec is an Innovation-driven Biotechnology company doing Research and Development, Manufacturing, Sales, Distribution and Marketing of Pharmaceuticals and Vaccines.
The international pharmaceutical formulations product portfolio includes highly innovative prescription products in niche therapeutic areas such as Pain, Diabetes & Cardiovascular management, Oncology, Renal Disease, Osteoporosis management and Gastro-intestinal care. Panacea Biotec has consolidated its presence in about 30 markets across CIS, Latin America, Middle East, Asia & Africa.
Panacea Biotec is one of India's largest Vaccine Manufacturing Company and is well acknowledged by the United Nations (UN) Health Agencies in partnering with the Global Polio Eradication Initiative (GPEI) with supplies of billions of doses of WHO Prequalified Polio vaccines in more than 50 countries worldwide.
Panacea Biotec was looking to implement Single Sign-On (SSO) and Multi-Factor Authentication (MFA) for MS365 apps hosted behind Netskope and Valgenesis applications using Active Directory Credentials.
Panacea Biotec desired to enable a quick and seamless login experience for its users and the security risks and challenges faced by Panacea Biotec required them to implement an advanced Multi-Factor Authentication (MFA) system to authenticate their users.
miniOrange implemented Single Sign-On (SSO) for Panacea Biotec which enabled users to quickly and easily login to their Microsoft and Valgensis applications using their Active Directory (AD) credentials.
miniOrange successfully implemented the desired Single Sign-On (SSO) and Multi-factor Authentication (MFA) solution for Panacea Biotec. By using miniOrange’s secure Single Sign-On (SSO) solution, Panacea Biotec users seamlessly logged into their application using their active directory credentials. This led to increased productivity and improved user experience.
Also, by implementing miniOrange’s Multi-factor authentication (MFA), Panacea Biotec benefited from enhanced security for their applications and reduced the chances of a user gaining unwanted access to the system. Overall, Panacea Biotec was able to cut down on its IT costs, and spend less time and resources on IT security management issues.